It was reported that a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with a grade of 3 and rotated heart.A mitraclip xtw was inserted and advanced to the mitral valve and while confirming trajectory, the oxygen level decreased in the middle of the mitraclip procedure.The patient was given 100% of oxygen density, and the procedure was continued.The mitraclip was successfully implanted, reducing the mr to a grade of 1.However, after removal of the steerable guide catheter (sgc), a right to left shunt from the interatrial septum was observed.Therefore, an atrial septal defect (asd) closure device was implanted.There was no clinically significant delay in the procedure.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, a cause of the reported hypoxia, associated with the decrease in blood oxygen level during the procedure, could not be determined.The reported perforation (atrial septal defect/ asd), associated with the right to left shunt at the interatrial septum, was due to procedural circumstances when high pressure was detected in right atrium.The reported patient effect of perforation, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|